These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11033327)

  • 1. The role of CRF receptor subtypes in stress-induced behavioural responses.
    Smagin GN; Dunn AJ
    Eur J Pharmacol; 2000 Sep; 405(1-3):199-206. PubMed ID: 11033327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of CRH in behavioral responses to stress.
    Smagin GN; Heinrichs SC; Dunn AJ
    Peptides; 2001 May; 22(5):713-24. PubMed ID: 11337084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor.
    Ho SP; Takahashi LK; Livanov V; Spencer K; Lesher T; Maciag C; Smith MA; Rohrbach KW; Hartig PR; Arneric SP
    Brain Res Mol Brain Res; 2001 Apr; 89(1-2):29-40. PubMed ID: 11311973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides.
    Turnbull AV; Rivier C
    Proc Soc Exp Biol Med; 1997 May; 215(1):1-10. PubMed ID: 9142133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiogenic-like effect of corticotropin-releasing factor receptor 2 antisense oligonucleotides infused into rat brain.
    Isogawa K; Akiyoshi J; Tsutsumi T; Kodama K; Horinouti Y; Nagayama H
    J Psychopharmacol; 2003 Dec; 17(4):409-13. PubMed ID: 14870953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological evidence supporting a role for central corticotropin-releasing factor(2) receptors in behavioral, but not endocrine, response to environmental stress.
    Pelleymounter MA; Joppa M; Ling N; Foster AC
    J Pharmacol Exp Ther; 2002 Jul; 302(1):145-52. PubMed ID: 12065711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems.
    Sandi C; Cordero MI; Ugolini A; Varea E; Caberlotto L; Large CH
    Eur J Neurosci; 2008 Nov; 28(9):1836-48. PubMed ID: 18973598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential monoaminergic, neuroendocrine and behavioural responses after central administration of corticotropin-releasing factor receptor type 1 and type 2 agonists.
    de Groote L; Peñalva RG; Flachskamm C; Reul JM; Linthorst AC
    J Neurochem; 2005 Jul; 94(1):45-56. PubMed ID: 15953348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell type-specific modifications of corticotropin-releasing factor (CRF) and its type 1 receptor (CRF1) on startle behavior and sensorimotor gating.
    Flandreau E; Risbrough V; Lu A; Ableitner M; Geyer MA; Holsboer F; Deussing JM
    Psychoneuroendocrinology; 2015 Mar; 53():16-28. PubMed ID: 25575243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin-releasing factor receptor type 2-deficient mice display impaired coping behaviors during stress.
    Coste SC; Heard AD; Phillips TJ; Stenzel-Poore MP
    Genes Brain Behav; 2006 Mar; 5(2):131-8. PubMed ID: 16507004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotrophin-releasing factor receptors: from molecular biology to drug design.
    Chalmers DT; Lovenberg TW; Grigoriadis DE; Behan DP; De Souza EB
    Trends Pharmacol Sci; 1996 Apr; 17(4):166-72. PubMed ID: 8984745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of CRF/CRFR1 signaling in the basolateral nucleus of the amygdala contributes to chronic forced swim-induced depressive-like behaviors in rats.
    Chen L; Li S; Cai J; Wei TJ; Liu LY; Zhao HY; Liu BH; Jing HB; Jin ZR; Liu M; Wan Y; Xing GG
    Behav Brain Res; 2018 Feb; 338():134-142. PubMed ID: 29080675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology and biology of corticotropin-releasing factor (CRF) receptors.
    Eckart K; Jahn O; Radulovic J; Radulovic M; Blank T; Stiedl O; Brauns O; Tezval H; Zeyda T; Spiess J
    Recept Channels; 2002; 8(3-4):163-77. PubMed ID: 12529934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain is a salient "stressor" that is mediated by corticotropin-releasing factor-1 receptors.
    Hummel M; Cummons T; Lu P; Mark L; Harrison JE; Kennedy JD; Whiteside GT
    Neuropharmacology; 2010 Sep; 59(3):160-6. PubMed ID: 20470804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stress-induced redistribution of corticotropin-releasing factor receptor subtypes in the dorsal raphe nucleus.
    Waselus M; Nazzaro C; Valentino RJ; Van Bockstaele EJ
    Biol Psychiatry; 2009 Jul; 66(1):76-83. PubMed ID: 19362706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prefrontal Cortex Corticotropin-Releasing Factor Receptor 1 Conveys Acute Stress-Induced Executive Dysfunction.
    Uribe-Mariño A; Gassen NC; Wiesbeck MF; Balsevich G; Santarelli S; Solfrank B; Dournes C; Fries GR; Masana M; Labermeier C; Wang XD; Hafner K; Schmid B; Rein T; Chen A; Deussing JM; Schmidt MV
    Biol Psychiatry; 2016 Nov; 80(10):743-753. PubMed ID: 27318500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing factor receptors: an overview.
    Dieterich KD; Lehnert H; De Souza EB
    Exp Clin Endocrinol Diabetes; 1997; 105(2):65-82. PubMed ID: 9137936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of corticotropin-releasing factor (CRF) receptor binding in the mouse brain using a new, high-affinity radioligand, [
    Tan LA; Vaughan JM; Perrin MH; Rivier JE; Sawchenko PE
    J Comp Neurol; 2017 Dec; 525(18):3840-3864. PubMed ID: 28842924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing Factor in the Rat Dorsal Raphe Nucleus Promotes Different Forms of Behavioral Flexibility Depending on Social Stress History.
    Snyder KP; Hill-Smith TE; Lucki I; Valentino RJ
    Neuropsychopharmacology; 2015 Oct; 40(11):2517-25. PubMed ID: 25865931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
    McCarthy JR; Heinrichs SC; Grigoriadis DE
    Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.